 |
| Mo’ Money, Mo’ Problemsby Osagie K. Obasogie, Biopolitical TimesApril 6th, 2007"Everyone has a price," goes the adage. Before last week, the FDA apparently thought this wasn't true for physicians, biomedical researchers, and others serving on advisory committees that give expert opinions on pending drug approvals. |
| Pushing the Chimeric Envelopeby Osagie K. Obasogie, Biopolitical TimesMarch 30th, 2007It was reported this week that Esmail Zanjani at the University of Nevada has created the first human-sheep chimera, with 15% human cells. |
| Genetic justice, industry styleby Marcy Darnovsky, Biopolitical TimesMarch 19th, 2007The issues raised by the intertwining of law and human biotechnologies are often technically and socially complex. What's a busy jurist to do? |
| Stem Cell Business Challengesby Marisa Taylor, Red HerringMarch 13th, 2007Small companies working to develop human embryonic stem cell therapies face innumerable challenges when looking for funding, according to several industry executives at the second annual Stem Cell Meeting in San Francisco on Monday. |
| General Electric profits on sex selection in Indiaby Marcy Darnovsky, Biopolitical TimesMarch 8th, 2007The Washington Times reports on the scores of thousands of specially designed low-cost ultrasound machines that have been manufactured by General Electric and the Bangalore software company Wipro, and sold with the help of cheap credit offered by GE Capital Services India. |
| The Gatekeeperby Kara Platoni, East Bay ExpressFebruary 28th, 2007What if scientists devised a strategy to tackle some of the world's most notorious diseases, but just one company held all the patents? |
|
|
 |
Highlighted Topics
